A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy-Reference-Cited by-同舟云学术

A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy

Published:2015-04-15 Issue:6 Volume:11 Page:1368-1386
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Kaumaya Pravin TP

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/21645515.2015.1026495

Reference187 articles.

1. Peptide vaccines and peptidomimetics targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy

2. Bridging oncology and immunology: expanding horizons with innovative peptide vaccines and peptidomimetics

3. Engineered Conformation-dependent VEGF Peptide Mimics Are Effective in Inhibiting VEGF Signaling Pathways

4. Current advances in humanized mouse models

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy;Frontiers in Chemistry;2023-01-17

2. HER2/neu-Based Peptide Vaccination-Pulsed with B-Cell Epitope Induced Efficient Prophylactic and Therapeutic Antitumor Activities in TUBO Breast Cancer Mice Model;Cancers;2021-10-01

3. Role of Different Peptides for Cancer Immunotherapy;International Journal of Peptide Research and Therapeutics;2021-09-23

4. A liposome-based cancer vaccine for a rapid and high-titre anti-ErbB-2 antibody response;European Journal of Pharmaceutical Sciences;2020-09

5. K-ras peptide mimotope induces a humoral immune response against G12V K-ras antigen in BALB/c mice;Asia Pacific Journal of Molecular Biology and Biotechnology;2020-07-09